Merosin-negative non-Fukuyama-type congenital muscular dystrophy: A case report

Brain and Development

Volumn 18, Issue 2, 1996, Pages 131-134

  Yamashita, Yushiro ^a   Ohtaki, Etsuo ^a   Matsuishi, Toyojiro ^a   Osari, Shin Ichi ^b   Kobayashi, Osamu ^b   Nonaka, Ikuya ^b  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

Author keywords

Computed tomography; Congenital muscular dystrophy; Magnetic resonance imaging; Merosin; Non Fukuyama type

Indexed keywords

CREATINE KINASE; MEROSIN;

ARTICLE; BRAIN TOMOGRAPHY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CREATINE KINASE BLOOD LEVEL; DEVELOPMENTAL DISORDER; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; INFANT; INTELLIGENCE QUOTIENT; MOTOR DEVELOPMENT; MUSCLE BIOPSY; MUSCLE CELL; MUSCLE HYPOTONIA; MUSCLE WEAKNESS; MUSCULAR DYSTROPHY; PNEUMONIA; PRESCHOOL CHILD; WHITE MATTER;

EID: 0029921882     PISSN: 03877604     EISSN: None     Source Type: Journal    
DOI: 10.1016/0387-7604(95)00140-9     Document Type: Article

References (12)

1. Tomé FMS, Evangelista T, Leclerc A, et al. Congenital muscular dystrophy with merosin deficiency. C R Acad Sci III (Paris) 1994; 317: 351-7.
2. Hillaire D, Leclerc A, Fauré S, et al. Localization of merosin-negative congenital dystrophy to chromosome 6q2 by homozygosity mapping. Hum Mol Genet 1994; 3: 1657-61.
3. Ohtani Y, Yoshioka K, Miike T, Ohta J, Kai Y. Merosin deficiency: the clinical and pathological features (in Japanese). No To Hattatsu (Tokyo) 1995; 27: S266.
4. Kobayashi O, Hayashi YK, Arahata K, et al. Congenital muscular dystrophy: clinical and pathologic study of 50 patients with the classical (occidental) merosin-positive form. Neurology (in press).
5. Philpot J, Sewry C, Pennock J, et al. Clinical phenotype in congenital muscular dystrophy: correlation with expression of merosin in skeletal muscle. Neuromusc Disord 1995; 5: 301-5.
6. Vuolteenaho R, Nissinen M, Sainio K, et al. Human laminin M chain (merosin): complete primary structure, chromosomal assignment, and expression of the M and A chain in human fetal tissues. J Cell Biol 1994; 124: 381-94.
7. Egger J, Kendall BE, Erdohazi M, et al. Involvement of the central nervous system in congenital muscular dystrophies. Dev Med Child Neurol 1983; 25: 32-42.
8. Yoshioka M, Kuroki S, Mizue H. Congenital muscular dystrophy of non-Fukuyama type with characteristic CT images. Brain Dev (Tokyo) 1987; 9: 316-8.
9. Yoshioka M, Okuno T, Ito M, et al. Congenital muscular dystrophy (Fukuyama type). Repeated CT studies in 19 children. Comput Tomogr 1981; 5: 81-8.
10. Hayashi YK, Engvall E, Arikawa-Hirasawa E, et al. Abnormal localization of laminin subunits in muscular dystrophies. J Neurol Sci 1993; 119: 53-64.
11. Toda T, Segawa M, Nomura Y, et al. Localization of gene for Fukuyama type congenital muscular dystrophy to chromosome 9q31-33. Nature Genet 1993; 5: 283-6.
12. 2) expression in skeletal muscle distinguishes Walker-Warburg syndrome from Fukuyama muscular dystrophy and merosin-deficient congenital muscular dystrophy. Neuropediatrics 1995; 26: 148-55.